NASDAQ:INCY
Incyte Corporation Stock News
$54.08
+0.320 (+0.595%)
At Close: May 06, 2024
Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder
11:12am, Wednesday, 04'th Dec 2019
Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder
Why Incyte Stock Climbed 12.2% in November
09:56am, Wednesday, 04'th Dec 2019
Strong sales for the company's main drug and potential new applications and treatments have pushed the pharma stock up 48% in 2019.
Why You Should Keep An Eye On These 5 Leading Health Care Stocks
09:00am, Tuesday, 03'rd Dec 2019
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Looking For Growth? Take A Look At These Biotechnology Stocks
11:00am, Monday, 02'nd Dec 2019
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.
The post Looking For Growth?
Why Is Incyte (INCY) Up 12.5% Since Last Earnings Report?
09:31am, Thursday, 28'th Nov 2019
Incyte (INCY) reported earnings 30 days ago. What's next for the stock?
Incyte's NDA for Pemigatinib Gets FDA's Priority Review Tag
08:10am, Thursday, 28'th Nov 2019
The FDA accepts and grants priority review to Incyte's (INCY) new drug application for pemigatinib as a second-line treatment for patients with FGFR2 translocated cholangiocarcinoma.
Nasdaq Soars To New High; Alibaba, Splunk, Incyte Break Out
04:09pm, Friday, 22'nd Nov 2019
Nasdaq, S&P 500 soar to new highs; Alibaba, Splunk, Incyte break out.
Investor's Business Daily's STOCK MARKET TODAY (Nov 20)
04:25pm, Wednesday, 20'th Nov 2019
Trade headlines steal the show as Target gaps up on earnings while Incyte and ServiceNow clear resistance.
Incyte (INCY) Is Up 1.88% in One Week: What You Should Know
10:00am, Wednesday, 20'th Nov 2019
Does Incyte (INCY) have what it takes to be a top stock pick for momentum investors? Let's find out.
4 Big Biotech Stocks Worth Considering Post Q3 Earnings
10:14am, Tuesday, 19'th Nov 2019
We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.
Incyte: A Buy On Revenue, EPS Growth And Strong Pipeline
10:20am, Friday, 15'th Nov 2019
Incyte: A Buy On Revenue, EPS Growth And Strong Pipeline
Top Health Care Stocks for November 2019
01:55pm, Thursday, 14'th Nov 2019
These are the health care stocks with the best value, fastest growth, and most momentum for November.
Final Trades: CVS, US Bancorp, Boston Scientific & more
01:28pm, Wednesday, 13'th Nov 2019
The "Halftime Report" traders give their top stocks to watch for the second half
